Biophytis

COVID test

Biotech

Pandemic tears up Biophytis' plans, limiting data and timelines

Biophytis has seen major disruptions to its pipeline due to the pandemic, including trial delays and data limitations.

Gabrielle Masson Apr 7, 2022 1:18pm

Stanislas Veillet

Biophytis raises $12M for trials of aging disease duo

Oct 11, 2017 9:45am